Skip to content

Aura Biosciences, Inc. AURA Retained Earnings

Retained Earnings at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$169.16B+4.0%
Merck & Co. logo
Merck & Co.MRK
$66.72B+0.9%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$4.36B-24.4%
UroGen Pharma logo
UroGen PharmaURGN
-$983.29M-15.7%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$835.08M-20.2%
CG Oncology logo
CG OncologyCGON
-$439.18M-74.0%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s retained earnings?
Aura Biosciences, Inc. (AURA) reported retained earnings of -$514.1M in Q1 2026.
How has Aura Biosciences, Inc.'s retained earnings changed year-over-year?
Aura Biosciences, Inc.'s retained earnings decreased by 28.0% year-over-year, from -$401.71M to -$514.1M.
What is the long-term trend for Aura Biosciences, Inc.'s retained earnings?
Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s retained earnings has grown at a 32.7% compound annual growth rate (CAGR), from -$116.89M to -$480.42M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.